We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+14.14%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$94.3B
AUM Growth
+$7.96B
(+9.2%)
Cap. Flow
-$2.37B
Cap. Flow
% of AUM
-2.52%
Top 10 Holdings %
Top 10 Hldgs %
12.56%
Holding
2,315
New
140
Increased
934
Reduced
1,002
Closed
155
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$335M |
| 2 |
Exelon
EXC
|
+$314M |
| 3 |
Procter & Gamble
PG
|
+$241M |
| 4 |
TripAdvisor
TRIP
|
+$208M |
| 5 |
Starbucks
SBUX
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$551M |
| 2 |
Target
TGT
|
+$514M |
| 3 |
CELG
Celgene Corp
CELG
|
+$495M |
| 4 |
Cigna
CI
|
+$369M |
| 5 |
Costco
COST
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.77% |
| 2 | Healthcare | 19.09% |
| 3 | Consumer Discretionary | 13.69% |
| 4 | Industrials | 9.28% |
| 5 | Financials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Magna International
MGA
$18.8B
| $199M | 0.21% |
4,095,947
+796,692
| +24% | +$40.2M |
|
|
PRAH
127
DELISTED
PRA Health Sciences, Inc.
PRAH
| $199M | 0.21% |
1,825,143
+597,699
| +49% | +$62.5M |
|
128
Eaton
ETN
$174B
| $198M | 0.21% |
2,464,795
+439,764
| +22% | +$33.5M |
|
129
MetLife
MET
$62.1B
| $198M | 0.21% |
4,645,305
+3,207,299
| +223% | +$142M |
|
130
Progressive
PGR
$125B
| $194M | 0.21% |
2,695,602
-950,298
| -26% | -$65.1M |
|
131
Zebra Technologies
ZBRA
$17.8B
| $194M | 0.21% |
926,303
+112,162
| +14% | +$21.1M |
|
132
Labcorp
LH
$25.9B
| $194M | 0.21% |
1,484,722
+454,097
| +44% | +$55.9M |
|
133
Xerox
XRX
$425M
| $193M | 0.2% |
6,036,585
+6,009,917
| +22,536% | +$169M |
|
134
AES
AES
$10.5B
| $191M | 0.2% |
10,575,916
+4,523,946
| +75% | +$76.1M |
|
|
ATH
135
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $191M | 0.2% |
4,692,433
+2,118,776
| +82% | +$90.7M |
|
136
United Airlines
UAL
$42.1B
| $191M | 0.2% |
2,401,959
-950,795
| -28% | -$80.2M |
|
137
CenterPoint Energy
CNP
$26.8B
| $191M | 0.2% |
6,221,359
+2,028,212
| +48% | +$61.3M |
|
138
Visa
V
$677B
| $189M | 0.2% |
1,212,302
-67,275
| -5% | -$9.7M |
|
139
Southwest Airlines
LUV
$23B
| $188M | 0.2% |
3,682,205
-2,359,755
| -39% | -$124M |
|
140
PBF Energy
PBF
$7.31B
| $188M | 0.2% |
6,039,220
-684,045
| -10% | -$23M |
|
141
CGI
GIB
$15.5B
| $188M | 0.2% |
2,735,290
-33,465
| -1% | -$2.21M |
|
142
Vistra
VST
$47.4B
| $186M | 0.2% |
7,171,363
-299,067
| -4% | -$7.55M |
|
143
Monster Beverage
MNST
$88.5B
| $186M | 0.2% |
6,900,128
+5,504,648
| +394% | +$157M |
|
144
Reinsurance Group of America
RGA
$16.1B
| $186M | 0.2% |
1,311,420
-235,658
| -15% | -$33.9M |
|
145
DTE Energy
DTE
$29.1B
| $184M | 0.19% |
1,738,236
+492,844
| +40% | +$49.8M |
|
146
Broadridge
BR
$19B
| $183M | 0.19% |
1,765,110
-304,887
| -15% | -$30.6M |
|
147
ExxonMobil
XOM
$634B
| $180M | 0.19% |
2,228,688
-986,221
| -31% | -$75.2M |
|
148
Cardinal Health
CAH
$55.4B
| $175M | 0.19% |
3,681,625
+978,044
| +36% | +$49M |
|
149
Veeva Systems
VEEV
$37.4B
| $175M | 0.19% |
1,389,186
+1,212,517
| +686% | +$137M |
|
150
Edwards Lifesciences
EW
$51.7B
| $172M | 0.18% |
2,720,520
+261,654
| +11% | +$14.9M |
|
Similar funds
VGA
AQR Capital Management's Q1 2019 Portfolio in Review
As of Q1 2019, AQR Capital Management held 2,315 positions worth $94.3B, up 9.2% from $86.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management's Q1 2019 filing shows 140 new, 934 increased, 1,002 reduced and 155 closed positions. Its largest new stake was Canopy Growth: 121,700 shares worth $52.7M. The largest sale was Walmart Inc, an estimated $551M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- AQR Capital Management's largest Q1 2019 buy was Canopy Growth: 121,700 shares worth $52.7M.
- AQR Capital Management added most to Biogen in Q1 2019, an estimated $335M increase.
- AQR Capital Management's biggest Q1 2019 reduction was Walmart Inc, cutting an estimated $551M.
- AQR Capital Management fully exited Dun & Bradstreet in Q1 2019, selling an estimated $74.4M.
- AQR Capital Management's ten largest holdings make up 13% of its $94.3B portfolio in Q1 2019.
- AQR Capital Management opened 140 new positions and closed 155 in Q1 2019.
- AQR Capital Management's portfolio value rose 9.2% quarter-over-quarter to $94.3B.
Based on AQR Capital Management's 13F filing for Q1 2019, filed 14 May 2019.